The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age4-7
SponsorKonkuk University Medical Center
About this trial
The present trial conducted to demonstrate the administration of sugammadex as reversal of neuromuscular blockade agent reduces the incidence of emergence agitation (EA) comparing to neostigmine
Eligibility criteria
Qualifiers
Patients scheduled elective strabismus surgery aged 4-7 with American Society of Anesthesiologists (ASA) classification 1-3.
Disqualifiers
ASA classification 3 or more
impaired liver function
impaired kidney function
myasthenia gravis or other neuromuscular disorders
Trial design
Treatments tested in this trial
- Bridion 200 MG in 2 ML Injection
- Pyridostigmine Bromide 5 MG/ML
Treatment groups
76 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov